Evidence map›Paper›PMID 32724495›Full record

ArticleOxidative medicine and cellular longevity2020

Protective Activities of

Xiangcheng Fan, Jichun Han, Lijun Zhu, Zhipeng Chen, Jiajing Li, Yue Gu, Feng Wang, Tao Wang, Yunyun Yue, Jing Shang

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Frontiers in nutrition · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Cholesterol-Lowering Effect of Polysaccharides fromFoods (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. The effects ofIranian journal of basic medical sciences · 2023
    Review
  17. Frontiers in pharmacology · 2022
    Review
  18. Zebrafish Model for Screening Antiatherosclerosis Drugs.Oxidative medicine and cellular longevity · 2021
    Article
  19. Article
  20. Mediators of inflammation · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiangcheng FanSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198 Jiangsu, China.ORCID https://orcid.org/0000-0001-9563-9701
Jichun HanSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198 Jiangsu, China.ORCID https://orcid.org/0000-0002-2650-0519
Lijun ZhuSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198 Jiangsu, China.ORCID https://orcid.org/0000-0001-9578-7624
Zhipeng ChenNanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 211166 Jiangsu, China.
Jiajing LiSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198 Jiangsu, China.
Yue GuDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210029 Jiangsu, China.ORCID https://orcid.org/0000-0002-6633-675X
Feng WangDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210029 Jiangsu, China.ORCID https://orcid.org/0000-0003-2771-5543
Tao WangJiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China.
Yunyun YueSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198 Jiangsu, China.ORCID https://orcid.org/0000-0003-1052-9015
Jing ShangSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198 Jiangsu, China.ORCID https://orcid.org/0000-0002-6757-8427
China Pharmaceutical University · CNNanjing Medical University · CNNanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease is the highest cause of death, and atherosclerosis (AS) is the primary pathogenesis of many cardiovascular diseases. In this study, we aim to investigate the possible pharmaceutical effects of

Indexed as

AnimalsAtherosclerosisDendrobiumDietHypercholesterolemiaPolysaccharidesZebrafishPolysaccharides

Identifiers

PMID32724495
PMCPMC7366212
OpenAlexW3041264367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.